Notice: Undefined offset: 1 in /var/www/tmr/wp-content/plugins/accelerated-mobile-pages/includes/vendor/amp/includes/utils/class-amp-image-dimension-extractor.php on line 244
GNS Investors Have Opportunity to Lead Genius Group Limited Securities Fraud Lawsuit Against Citadel Securities LLC and Virtu Americas LLC - The Malaysian Reserve
Categories: PR Newswire

GNS Investors Have Opportunity to Lead Genius Group Limited Securities Fraud Lawsuit Against Citadel Securities LLC and Virtu Americas LLC

NEW YORK, July 7, 2026 /PRNewswire/ —

Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 28, 2026.

So What: If you purchased or sold Genius securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Genius class action, go to https://rosenlegal.com/cases/genius-group-limited/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 28, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, throughout the Class Period, defendants engaged in a manipulative and illegal trading practice known as “spoofing,” which involves submitting and then cancelling buy or sell orders without any genuine intent to execute them. The purpose of these “baiting orders” was to mislead other market participants about the true level of supply and demand for Genius securities, or about the stock’s price volatility, thereby influencing the market price of Genius to benefit defendants’ own trading positions. The alleged manipulation also increased investors’ transaction costs by inflating the bid-ask spread for Genius stock. Defendants entered thousands of these baiting orders on U.S. stock exchanges to create the false impression that Genius’ stock price reflected genuine supply-and-demand and volatility dynamics, while simultaneously profiting by absorbing and reselling their customers’ order flow at prices favorable to defendants.

To join the Genius class action, go to https://rosenlegal.com/cases/genius-group-limited/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     case@rosenlegal.com
     www.rosenlegal.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/gns-investors-have-opportunity-to-lead-genius-group-limited-securities-fraud-lawsuit-against-citadel-securities-llc-and-virtu-americas-llc-302819974.html

SOURCE THE ROSEN LAW FIRM, P. A.

Share
Published by

    Notice: Trying to get property of non-object in /var/www/tmr/wp-content/plugins/nextgen-gallery/products/photocrati_nextgen/modules/third_party_compat/module.third_party_compat.php on line 473

    Notice: Trying to get property of non-object in /var/www/tmr/wp-content/plugins/nextgen-gallery/products/photocrati_nextgen/modules/third_party_compat/module.third_party_compat.php on line 473

Recent Posts

/C O R R E C T I O N — Lazada Group/

In the news release, Lazada Joins Meta's Affiliate Partnerships Programme to Streamline Social Shopping in…

15 mins ago

COMING IN HOT. ABSOLUT AND TABASCO® LAUNCH NEW SPICY VODKA

Two global titans of flavour join forces to launch a unique spicy vodka as consumer…

38 mins ago

Shanghai to host pioneering international AI conference

WAIC 2026 unites industry leaders to advance dialogue and collaborationBEIJING, July 7, 2026 /PRNewswire/ --…

48 mins ago

MEDIPOST Inc. Treats First U.S. Participant in Phase III Trial of Umbilical Cord Stem Cell Therapy for Symptomatic Cartilage Defects Due to Knee Osteoarthritis

U.S. Phase III Trial Expands Clinical Investigation of Stem Cell Therapy for Knee Cartilage DefectsCAMBRIDGE,…

1 hour ago

Merz Aesthetics Presents Ultherapy Mask – PDRN Peptide Radiance and Launches its 2026 Campaign at the Ultherapy PRIME Soirée in Malaysia

Merz Aesthetics introduces its 2026 campaign "See My Skin, Lift My Way", celebrating individuality, authenticity…

1 hour ago

How Vietnam is Redrawing the Southeast Asian Tourism Map with Near-50% Increase in International Search Interest

SINGAPORE, July 8, 2026 /PRNewswire/ -- Digital travel platform Agoda has recorded close to a 50%…

2 hours ago